Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | |
|---|---|---|---|---|---|
| Total revenue | -1.34%43.13M | 13.63%43.72M | -14.80%38.47M | -6.49%45.16M | 48.29M |
| Operating revenue | -1.34%43.13M | 13.63%43.72M | -14.80%38.47M | -6.49%45.16M | --48.29M |
| Cost of revenue | 19.69%17.84M | 21.07%14.91M | -33.35%12.31M | -23.94%18.47M | 24.29M |
| Gross profit | -12.22%25.29M | 10.13%28.81M | -1.96%26.16M | 11.18%26.68M | 24M |
| Operating expense | 10.01%20.02M | -22.04%18.2M | 21.62%23.34M | -13.29%19.19M | 22.13M |
| Selling and administrative expenses | -82.30%1.52M | 2.90%8.56M | -1.05%8.32M | -17.73%8.41M | --10.22M |
| -Selling and marketing expense | -47.15%15.77K | -24.94%29.84K | -70.43%39.76K | -58.20%134.45K | --321.65K |
| -General and administrative expense | -82.42%1.5M | 3.03%8.53M | 0.08%8.28M | -16.41%8.27M | --9.9M |
| Depreciation amortization depletion | -47.44%199.3K | 55.40%379.21K | -61.22%244.03K | -43.63%629.32K | --1.12M |
| -Depreciation and amortization | -47.44%199.3K | 55.40%379.21K | -61.22%244.03K | -43.63%629.32K | --1.12M |
| Provision for doubtful accounts | 45.16%1.21M | 9.96%836.76K | 5.73%760.98K | 75.32%719.71K | --410.5K |
| Other operating expenses | 102.94%17.09M | -39.93%8.42M | 48.56%14.02M | -9.16%9.44M | --10.39M |
| Operating profit | -50.31%5.27M | 276.55%10.61M | -62.37%2.82M | 301.28%7.49M | 1.87M |
| Net non-operating interest income (expenses) | -1.74%-21.43M | 13.11%-21.06M | 32.63%-24.24M | 9.32%-35.97M | -39.67M |
| Non-operating interest income | -4.99%461.21K | 50.87%485.44K | -35.45%321.76K | -61.35%498.47K | --1.29M |
| Non-operating interest expense | 1.59%21.89M | -12.27%21.54M | -32.67%24.56M | -10.96%36.47M | --40.96M |
| Other net income (expenses) | -111.90%-3.02M | -24.58%25.37M | 154.56%33.64M | 59.01%-61.66M | -150.42M |
| Special income (charges) | ---489.97K | ---- | ---- | 103.81%95.45K | ---2.51M |
| -Less:Impairment of capital assets | --489.97K | ---- | ---- | -103.81%-95.45K | --2.51M |
| Other non-operating income (expenses) | -109.96%-2.53M | -24.92%25.37M | 154.86%33.79M | 59.36%-61.6M | ---151.58M |
| Income before tax | -228.41%-19.17M | 22.10%14.93M | 113.56%12.23M | 52.11%-90.14M | -188.23M |
| Income tax | -101.54%-123.21K | 189.95%8.02M | -265.78%-8.91M | 115.95%5.38M | -33.71M |
| Earnings from equity interest net of tax | |||||
| Net income | -375.63%-19.05M | -67.31%6.91M | 122.13%21.14M | 38.18%-95.52M | -154.51M |
| Net income continuous operations | -375.63%-19.05M | -67.31%6.91M | 122.13%21.14M | 38.18%-95.52M | ---154.51M |
| Noncontrolling interests | -79.88K | ||||
| Net income attributable to the company | -374.47%-18.97M | -67.31%6.91M | 122.13%21.14M | 38.18%-95.52M | -154.51M |
| Preferred stock dividends | 0.00%12.44M | 12.44M | |||
| Other under preferred stock dividend | |||||
| Net income attributable to common stockholders | -374.47%-18.97M | -67.31%6.91M | 119.58%21.14M | 35.33%-107.96M | -166.95M |
| Diluted earnings per share | |||||
| Basic earnings per share | |||||
| Dividend per share | |||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |